首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1424309

全球經腸營養製劑市場：按產品類型、按流程類型、按階段、按適應症、按最終用途、按銷售管道、按地區

Global Enteral Feeding Formulas Market, By Product, By Flow Type, By Stage, By Indication, By End Use (Hospitals, Home Care), By Sales Channel, By Geography

出版日期: 2023年12月28日 | 出版商:

Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

經腸營養製劑的全球市場規模預計將從 2023 年的 57.9 億美元增至 2030 年的 109.4 億美元，預測期內複合年成長率為 9.5%。

報告範圍		報告詳情
基準年	2022年	2023/2024年市場規模	57.9億美元
過去的資料	2018-2021	預測期	2023-2030
預測期間 2023/2024 至 2030/2031 年複合年成長率：	9.50%	2030/2031價值預測	109.4億美元

圖 1. 2023 年經腸營養產品的全球市場佔有率（按地區分類）

經腸營養製劑食品直接給予無法充分口服攝取的人的胃、十二指腸或空腸的營養補充。經腸營養製劑有許多不同類型。以蛋白質為主要營養素的經腸營養配方食品，適用於需要補充營養但碳水化合物或脂肪攝取量極少的人。標準經腸營養配方含有均衡的碳水化合物、蛋白質和脂肪組合。這些配方可以滿足您大部分日常營養需求，適合長期使用。特異性疾病的處方是針對特定的健康狀況而量身定做的，例如糖尿病、腎衰竭或肝病。含膳食纖維製劑含有可溶性和不可溶性膳食纖維，可促進腸道正常功能。

每種類型都有優點和缺點。以蛋白質為基礎的配方奶粉有助於滿足蛋白質需求，而不會攝取過多的熱量，但它們缺乏均衡的營養。標準配方奶粉提供均衡的營養，但可能無法滿足特殊的用餐需求。針對特異性疾病的配方可滿足特定疾病的獨特營養需求，但價格昂貴。含有膳食纖維的配方奶有助於規律排便，但更濃稠且熱量更高。應根據個人的健康狀況、營養需求和耐受性選擇合適的治療方案。經腸營養可以確保無法透過口服攝取營養的患者獲得充足的營養。

市場動態：.

全球經腸營養產品市場是由老年人口增加、慢性病患病率增加、早產數量增加以及成人吞嚥困難迅速增加所推動的。根據聯合國的預測，到2050年，60歲及以上的人口將增加近一倍，超過年輕人口。老年人更有可能出現需要經腸營養支持的疾病，例如失智症或手術後併發症。此外，國際上需要經腸營養支持的慢性疾病的數量正在增加，例如癌症、神經系統疾病和胃腸道疾病。這對市場成長產生正面影響。然而，替代輸送方法的可用性、與管相關的感染風險以及特種配方的高成本正在限制市場成長。有機、非基因改造和無過敏原配方的市場開拓為市場參與者提供了利潤豐厚的機會。

本研究的主要特點

本報告對全球經腸營養製劑市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
它揭示了各個細分市場的潛在收益成長機會，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球經腸營養製劑市場的主要企業。
該報告的見解將使行銷人員和公司負責人能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球經腸營養製劑市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球經腸營養製劑市場的各種策略矩陣來促進他們的決策。

北美洲
美國
加拿大
歐洲
德國
英國
西班牙
法國
義大利
俄羅斯
其他歐洲國家
亞太地區
中國
印度
日本
澳洲
韓國
ASEAN
其他亞太地區
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
北非
中部非洲
南非

第12章競爭形勢

Nestle
VICTUS
Primus Pharmaceuticals, Inc.
Meiji Holdings. Co., Ltd.
Mead Johnson & Company, LLC
Abbott
Danone SA
Fresenius Kabi AG

第13章

調查方法
關於出版商

簡介目錄

Product Code: CMI6515

The Global Enteral Feeding Formulas Market size is expected to reach US$ 10.94 Bn by 2030, from US$ 5.79 Bn in 2023, exhibiting a CAGR of 9.5% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023/2024:	US$ 5.79 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR:	9.50%	2030/2031 Value Projection:	US$ 10.94 Bn

Figure 1. Global Enteral Feeding Formulas Market Share (%), By Region, 2023

Global Enteral Feeding Formulas Market - IMG1

Enteral feeding formulas are nutritional supplements that are administered directly into the stomach, duodenum, or jejunum of individuals who cannot obtain adequate oral intake. There are different types of enteral feeding formulas available. Protein-based formulas contain protein as the main nutrient and are used for individuals who need nutrition support but minimal carbohydrate or fat intake. Standard formulas provide a balanced proportion of carbohydrates, proteins, and fats. They meet most daily nutritional needs and are suitable for long-term use. Disease-specific formulas are tailored for certain health conditions like diabetes, renal failure, or liver disease. Fiber-containing formulas provide soluble and insoluble fiber to promote normal bowel function.

Each type of formula has its own advantages and disadvantages. Protein-based formulas help meet protein needs without excess calories but lack balanced nutrition. Standard formulas provide balanced nutrition but may not meet special dietary needs. Disease-specific formulas address the unique nutritional requirements of certain illnesses but come at a higher cost. Fiber-containing formulas aid in regular bowel movements but have a thicker consistency and higher calorie content. The appropriate formula must be selected based on the individual's health status, nutritional requirements, and tolerateability. Enteral feeding ensures adequate nutrition in patients who cannot obtain nutrition through oral intake.

Market Dynamics:

The global enteral feeding formulas market is driven by the rising geriatric population, increasing incidence of chronic diseases, growing number of preterm births, and surging cases of dysphagia among adults. As per UN projections, the population aged 60 years and above will nearly double by 2050 and become larger than the youth population. The aged people is more prone to conditions requiring enteral feeding assistance like dementia and complications post-surgery. Additionally, chronic diseases like cancer, neurological disorders, and gastrointestinal illnesses, necessitating enteral nutrition aids are on the rise internationally. This is positively impacting the market growth. However, the availability of alternative delivery methods, risk of infections associated with tubes, and high costs of specialized formulas are restraining the market growth. The development of organic, non-GMO (non-genetically modified organisms), and allergen-free formulas presents lucrative opportunities for market players.

Key Features of the Study:

This report provides an in-depth analysis of the global enteral feeding formulas market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global enteral feeding formulas market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Nestle, VICTUS, Primus Pharmaceuticals, Inc., Meiji Holdings. Co., Ltd., Mead Johnson & Company, LLC, Abbott, Danone S.A, and Fresenius Kabi AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global enteral feeding formulas market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global enteral feeding formulas market

Global Enteral Feeding Formulas Market Detailed Segmentation:

By Product
- Standard Formula
- Disease-specific Formulas
- Elemental Formulas
- Specialized Formulas
By Flow Type
- Intermittent Feeding Flow
- Continuous Feeding Flow
By Stage
- Adults
- Pediatrics
By Indication
- Alzheimer's
- Nutrition Deficiency
- Cancer Care
- Diabetes
- Chronic Kidney Diseases
- Orphan Diseases
- Dysphagia
- Pain Management
- Others (Malabsorption/GI Disorder/Diarrhea, etc.)
By End Use
- Hospitals
- Cardiology
- Neurology
- Critical Care (ICU)
- Oncology
- Others
- Home Care
By Sales Channel
- Online Sales
- Retail Sales
- Institutional Sales
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Key Players
- Nestle
- VICTUS
- Primus Pharmaceuticals, Inc.
- Meiji Holdings. Co., Ltd.
- Mead Johnson & Company, LLC
- Abbott
- Danone S.A
- Fresenius Kabi AG

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Enteral Feeding Formulas Market, By Product
- Global Enteral Feeding Formulas Market, By Flow Type
- Global Enteral Feeding Formulas Market, By Stage
- Global Enteral Feeding Formulas Market, By Indication
- Global Enteral Feeding Formulas Market, By End User
- Global Enteral Feeding Formulas Market, By Sales Channel
- Global Enteral Feeding Formulas Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Rising incidence of chronic diseases
- Changes in healthcare landscape and reimbursement policies
- Increasing preference for homecare services
Impact Analysis
Key Highlights
Regulatory Scenario
Service offering Portfolio
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Pipeline Analysis

4. Global Enteral Feeding Formulas Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Enteral Feeding Formulas Market, By Product, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Standard Formula
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Disease-specific Formulas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Elemental Formulas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Specialized Formulas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Enteral Feeding Formulas Market, By Flow Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Intermittent Feeding Flow
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Continuous Feeding Flow
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Enteral Feeding Formulas Market, By Stage, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Enteral Feeding Formulas Market, By Indication, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Alzheimer's
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Nutrition Deficiency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Cancer Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Chronic Kidney Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Orphan Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Dysphagia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others (Malabsorption/GI Disorder/Diarrhea, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

9. Global Enteral Feeding Formulas Market, By End User, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Cardiology
Neurology
Critical Care (ICU)
Oncology
Others
Home Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

10. Global Enteral Feeding Formulas Market, By Sales Channel, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Online Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Retail Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Institutional Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

11. Global Enteral Feeding Formulas Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stage, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stage, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stage, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stage, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stage, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stage, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
North Africa
Central Africa
South Africa

12. Competitive Landscape

Nestle
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
VICTUS
Primus Pharmaceuticals, Inc.
Meiji Holdings. Co., Ltd.
Mead Johnson & Company, LLC
Abbott
Danone S.A
Fresenius Kabi AG
Analyst Views